Circulating Levels of Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) are Associated With Monocyte Subsets in Patients With Stable Coronary Artery Disease

被引：0
|
作者：
Krychtiuk, Konstantin
Lenz, Max
Hohensinner, Philipp
Distelmaier, Klaus
Schrutka, Lore
Kastl, Stefan
Pfaffenberger, Stefan
Huber, Kurt
Hengstenberg, Christian
Wojta, Johann
Speidl, Walter S.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.15930
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15930
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis
    Lu, Xinjie
    CURRENT DRUG TARGETS, 2019, 20 (10) : 1029 - 1040
  • [32] Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
    Xuhui Bao
    Yongjun Liang
    Hanman Chang
    Tianji Cai
    Baijie Feng
    Konstantin Gordon
    Yuekun Zhu
    Hailian Shi
    Yundong He
    Liyi Xie
    Signal Transduction and Targeted Therapy, 9
  • [33] Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum
    Jabor, Antonin
    Vackova, Tereza
    Kubicek, Zdenek
    Komrskova, Jitka
    Protus, Marek
    Franekova, Janka
    CLINICA CHIMICA ACTA, 2021, 521 : 59 - 63
  • [34] PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
    Shimada, Yuichi J.
    Cannon, Christopher P.
    EUROPEAN HEART JOURNAL, 2015, 36 (36) : 2415 - U36
  • [35] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
    O'Connell, Emma M.
    Lohoff, Falk W.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [36] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors, Reality or Dream in Managing Patients with Cardiovascular Disease
    Alkhalil, Mohammad
    CURRENT DRUG METABOLISM, 2019, 20 (01) : 72 - 82
  • [37] Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer
    Bhattacharya, Anindita
    Chowdhury, Abhirup
    Chaudhury, Koel
    Shukla, Praphulla Chandra
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [38] Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a novel psoriasis susceptibility locus
    Merleev, A.
    Toussi, A.
    Downing, L.
    Tran, M.
    Nava, J.
    Le, S.
    Marusina, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S1 - S1
  • [39] Involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in aortic valvular calcification
    Poggio, P.
    Songia, P.
    Chiesa, M.
    Barbieri, S.
    Moschetta, D.
    Valerio, V.
    Cavallotti, L.
    Ferri, N.
    Zanotti, I.
    Camera, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1057 - 1057
  • [40] Procalcific effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) in chronic kidney disease (CKD)
    Ferri, N.
    Lupo, M. G. P.
    Rattazzi, M. R.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3652 - 3652
12345